Potentiation of the Effect of Erlotinib by Genistein in Pancreatic Cancer: The Role of Akt and Nuclear Factor- B

Cancer Research- United States

doi 10.1158/0008-5472.can-06-2333

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

The Role of the Transcription Factor Nuclear Factor-Kappa B in Thyroid Autoimmunity and Cancer

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2018English

The Regulatory Role of Nuclear Factor Kappa B in the Heart of Hereditary Hypertriglyceridemic Rat

Oxidative Medicine and Cellular Longevity
BiochemistryMedicineCell BiologyAging
2016English

Targeting Nuclear Factor Kappa B for the Treatment of Prostate Cancer

2005English

Role of Nuclear Factor-Kappa B in Feline Injection Site Sarcoma

BMC Veterinary Research
MedicineVeterinary
2019English

Retraction: Apoptosis-Inducing Effect of Erlotinib Is Potentiated by 3,3′-Diindolylmethane in Vitro and in Vivo Using an Orthotopic Model of Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Gemcitabine Overcomes Erlotinib Resistance in EGFR-Overexpressing Cancer Cells Through Downregulation of Akt

Journal of Cancer
Oncology
2011English

Up-Regulation of IGF2BP2 by Multiple Mechanisms in Pancreatic Cancer Promotes Cancer Proliferation by Activating the PI3K/Akt Signaling Pathway

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Assessing the Benefit–risk of New Treatments Using Generalised Pairwise Comparisons: The Case of Erlotinib in Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Internalin B Activates Nuclear Factor-κB via Ras, Phosphoinositide 3-Kinase, and Akt

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy